🇺🇸 Bevacizumab-awwb in United States

23 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Chest Discomfort — 4 reports (17.39%)
  2. Headache — 3 reports (13.04%)
  3. Chest Pain — 2 reports (8.7%)
  4. Death — 2 reports (8.7%)
  5. Flushing — 2 reports (8.7%)
  6. Infusion Related Reaction — 2 reports (8.7%)
  7. Nausea — 2 reports (8.7%)
  8. No Adverse Event — 2 reports (8.7%)
  9. Pain — 2 reports (8.7%)
  10. Rash — 2 reports (8.7%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Bevacizumab-awwb approved in United States?

Bevacizumab-awwb does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Bevacizumab-awwb in United States?

Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.